Description of Business Nordson is an innovative precision technology company that leverages a scalable growth framework to deliver top tier growth with leading margins and returns. We engineer, manufacture and market differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and…
$288.98
$4.38 (-1.49%)
EOD Jul 17, 2026
25.49% operating margin is above average. ROIC at 11.52%.
Revenue grew 3.8%, steady but not accelerating.
At 31x earnings, the current multiple leaves limited room for execution misses or growth deceleration.
30.9x earnings, 22.7x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$2.90B
▲ +3.8% YoY
Net Income (TTM)
$528M
▲ +3.7% YoY
Op. Margin
26.37%
▲ +0.4pp YoY
ROIC
12.48%
Cash Flow & Balance Sheet
FCF (TTM)
$714M
▲ +34.4% YoY
Op. Cash Flow (TTM)
$762M
▲ +29.3% YoY
Net Debt
$1.87B
Cash & Equiv.
$102M
5Y CAGR: +5.6%
5Y CAGR: +7.9%
Continue Research
At a P/E of 30.9 and a price-to-free-cash-flow of 22.7, Nordson (NDSN) trades above a two-stage DCF intrinsic value of about $266.76 per share, so at $288.98 the stock looks overvalued (7.7% above estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Nordson scores 58/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 1.1%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $266.76 per share for NDSN, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $200.07. At today's $288.98, that puts the stock about 7.7% above estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Nordson scores 58 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 26.4% operating margin and a 12.5% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Nordson pays a regular dividend of about $3.24 per share per year (typically in quarterly installments), a yield of roughly 1.1% at the current price. That is a payout ratio of about 34.4% of earnings, so the dividend is amply covered by earnings. Nordson has grown the dividend at roughly 16.4% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For NDSN's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. NDSN currently trades above its estimated intrinsic value and scores 58/100 on quality (mixed). It also yields about 1.1%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.